- Trials with a EudraCT protocol (235)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (12)
235 result(s) found for: Catheterization.
Displaying page 1 of 12.
EudraCT Number: 2005-004150-27 | Sponsor Protocol Number: KAR0001HEARTCAT | Start Date*: 2005-11-03 |
Sponsor Name:Universitätsklinik für Kinder- und Jugendheilkunde | ||
Full Title: RANDOMIZED CONTROLLED TRIAL COMPARING TWO HEPARINIZATION PROTOCOLS FOR PROPHYLAXIS OF SHORT- AND LONG-TERM THROMBOTIC COMPLICATIONS OF PEDIATRIC CARDIAC CATHETERIZATION The HEARTCAT – Study (HEpar... | ||
Medical condition: Patients requiring diagnostic or interventional cardiac catheterisation (without Stent, device or catheter ablation) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002469-37 | Sponsor Protocol Number: CRO-2012-17 | Start Date*: 2012-09-28 | |||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO | |||||||||||||
Full Title: Phase II clinical study on the efficacy and safety of procedural analgesia of oral transmucosal fentanyl citrate in oncologic patients eligible to permanent central venous catheter | |||||||||||||
Medical condition: Cancer patients eligible to permanent central venous catheter due to chemotherapeutic treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001071-30 | Sponsor Protocol Number: V1 | Start Date*: 2010-01-21 |
Sponsor Name:Medical University Vienna- Dept. of Pediatric Hemostaselology | ||
Full Title: Aspirin Resistance in Children after Interventional Cardiac Catheterization: The ARC Study | ||
Medical condition: children after interventional cardiac catheterization. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002258-56 | Sponsor Protocol Number: SD-DXP | Start Date*: 2018-08-27 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: The use of xenon and dexmedetomidine for the prevention of postoperative emergence delirium after anaesthesia for pediatric cardiac catheterization: A randomized, controlled, observer-blinded pilot... | ||
Medical condition: xenon-dexmedetomidine Anesthesia in children undergoing cardiac catheterization | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007179-18 | Sponsor Protocol Number: LACTO 07 | Start Date*: 2008-02-15 | |||||||||||
Sponsor Name:SOFAR SPA | |||||||||||||
Full Title: Evaluation of the ability of the probiotic Lactobacillus casei DG (Enterolactis) to remain into the bladder of patients with spinal cord injury and subject to intermitted catheterization. An open-l... | |||||||||||||
Medical condition: patients with spinal cord injury and subject to intermitted vesical catheterization and recurrence of urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000625-30 | Sponsor Protocol Number: INOT22 | Start Date*: 2004-07-21 |
Sponsor Name:INO Therapeutics | ||
Full Title: Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing | ||
Medical condition: : Nitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023814-29 | Sponsor Protocol Number: CAS110775 | Start Date*: 2011-06-17 | |||||||||||
Sponsor Name:Instituto Científico y Tecnológico de Navarra | |||||||||||||
Full Title: Concentración y actividad antibiótica en soluciones de sellado | |||||||||||||
Medical condition: Pacientes con catéter venoso central con reservorio subcutáneo | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002510-23 | Sponsor Protocol Number: SR062014 | Start Date*: 2014-09-17 |
Sponsor Name:University hospitals of Leuven | ||
Full Title: as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: a randomized controlled clinical trial | ||
Medical condition: Xenon anesthesia in children undergoing cardiac catheterization | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000166-37 | Sponsor Protocol Number: AIR001-CS05 | Start Date*: 2013-01-22 |
Sponsor Name:Aires Pharmaceuticals Inc | ||
Full Title: A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects with WHO Group 1 Pulmonary Arterial Hypertension | ||
Medical condition: Pulmonary Arterial Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-006748-76 | Sponsor Protocol Number: A1481244 | Start Date*: 2008-04-23 | |||||||||||
Sponsor Name:Pfizer Ltd. Ramsgate Road, Sandwich, Kent, UK | |||||||||||||
Full Title: A MULTINATIONAL, MULTICENTRE, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF 1 MG, 5MG AND 20 MG TID OF ORAL SILDENAFIL IN THE TREATMENT OF SUBJECTS AGED 18 YEA... | |||||||||||||
Medical condition: Pulmonary arterial hypertension (PAH). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) DK (Prematurely Ended) BE (Completed) IT (Prematurely Ended) GR (Prematurely Ended) LV (Prematurely Ended) GB (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000021-57 | Sponsor Protocol Number: 01000 | Start Date*: 2006-03-10 |
Sponsor Name:Rigshospitalet | ||
Full Title: Bosentan and Sildenfil for patients with Eisenmenger syndrome | ||
Medical condition: Eisenmengers syndrome is condition with severe pulmonary arterial hypertension due to a shunting of blood from the left side of the heart to the right side of the heart. When the pressure in the pu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001818-42 | Sponsor Protocol Number: C41750/3100 | Start Date*: 2016-04-14 | |||||||||||
Sponsor Name:Teva Branded Pharmaceutical Products R&D, Inc. | |||||||||||||
Full Title: A Double-blind, Randomized, Sham–procedure–controlled, Parallel-group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (rexlemestrocel-L) in Patients with Chronic Heart Failure D... | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Prematurely Ended) GB (Prematurely Ended) LT (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022820-61 | Sponsor Protocol Number: Tad-10 | Start Date*: 2010-10-14 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: PHASE CONTRAST MAGNETIC RESONANCE (MR) IMAGING IN MONITORING THE EFFECTS OF TADALAFIL IN PATIENTS WITH OUT-OF-PROPORTION PULMONARY HYPERTENSION AND LEFT VENTRICULAR DYSFUNCTION | |||||||||||||
Medical condition: Pulmonary Hypertension ``out-of-proportion`` associated to moderate left ventricular dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004828-11 | Sponsor Protocol Number: RECHMPL18_0038_prom_7574 | Start Date*: Information not available in EudraCT |
Sponsor Name:University Hospital of Montpellier | ||
Full Title: Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III study | ||
Medical condition: adult and adolescent patients with univentricular heart diseases and pulmonary arterial pressure | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004485-28 | Sponsor Protocol Number: 38RC15.214 | Start Date*: 2016-01-18 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Grenoble | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Patients should be operated for cardiac surgery with cardiac bypass and in sinus rhythm, and for which the fact of the existence of impaired left ventricular function or the heaviness of the surgic... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004815-29 | Sponsor Protocol Number: ULA03 | Start Date*: 2021-08-04 | |||||||||||
Sponsor Name:Cardiorentis AG | |||||||||||||
Full Title: Open-label, dose escalation study of ularitide for the investigation of hemodynamic effects in patients with pulmonary arterial hypertension (UPAH) | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024485-21 | Sponsor Protocol Number: daisy | Start Date*: 2013-04-15 |
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | ||
Full Title: Dipyridamole versus Adenosine infusion in the physiologic assessment of Intermediate coronary Stenoses in the cardiac catheterization laboratorY | ||
Medical condition: Patients with a single ≥ 50% e <75% coronary stenosis (visually extimated) at angiography, in one ore more coronary vessels). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012450-20 | Sponsor Protocol Number: AC-051-206 | Start Date*: 2009-10-15 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | |||||||||||||
Full Title: Multicenter, open-label, non-comparative, proof-of-concept, phase 2a study to evaluate the effect of a single infusion of tezosentan on pulmonary vascular resistance in patients with stable, chroni... | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003310-39 | Sponsor Protocol Number: 2021_CHUSTP_DAPAMICRO | Start Date*: 2021-10-29 |
Sponsor Name:CHU Saint Pierre | ||
Full Title: Effect of the antidiabetic drug DAPAgliflozin on the coronary macrovascular and MICROvascular function in type 2 diabetic patients (DAPAMICRO) | ||
Medical condition: Coronary macrovascular and microvascular function of type 2 diabetic patients with stable coronary artery disease and acute coronary syndrome (excluding ST elevation myocardial infarction). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000321-12 | Sponsor Protocol Number: 001/2016 | Start Date*: 2018-02-08 | |||||||||||
Sponsor Name:ÁREA DE ATENCIÓN INTEGRADA DE ALBACETE | |||||||||||||
Full Title: Effectiveness in preventing RAdial Spasm of different vasoDIlators and topic Local Anaesthesia during transradial cardiac catheterization: The E-RADIAL trial. | |||||||||||||
Medical condition: Radial spasm during cardiac catheterization | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.